Target intelligence / Profile preview

EGF-like, fibronectin type-III and laminin G-like domain-containing protein (EGFLAM)

Target
EGFLAM
Molecular classification
Other (extracellular matrix-like protein)
01

Overview

EGF-like, fibronectin type-III and laminin G-like domain-containing protein (EGFLAM), commonly known as pikachurin, is a highly conserved, retina-specific, extracellular matrix-like protein essential for the formation and maintenance of the photoreceptor ribbon synapse. Pikachurin is encoded by the EGFLAM gene and comprises 1,017 amino acids, containing two fibronectin type III (FN3) domains, three laminin G domains, and two EGF-like domains[1][4][5]. It acts as a dystroglycan-binding protein that bridges pre-synaptic photoreceptor dystroglycan complexes with post-synaptic GPR179 orphan receptors on bipolar cells, thereby ensuring precise synaptic alignment and effective visual signaling[1][3]. Defects in pikachurin or its binding to dystroglycan have been associated with congenital muscular dystrophies presenting with ocular symptoms, as well as other retinal synaptic dysfunctions[1][3]. Although critical to synaptic structure in the retina and linked to inherited eye diseases, pikachurin/EGFLAM is not a current direct therapeutic drug target and has no known drug interactions[1][3][4][5].

Other names
PikachurinAGRINLAGRNLPIKAFLJ39155Agrin-like proteinagrin-like proteinEGF-like, fibronectin type-III and laminin G-like domain-containing protein
02

Biological functions

Synaptic organizationSynaptogenesisExtracellular matrix interactionVisual signal transmission
03

Disease associations

Neurodevelopmental diseaseEye abnormalitiesMuscular dystrophyOcular pathology

Beyond the preview

Go deeper on EGF-like, fibronectin type-III and laminin G-like domain-containing protein (EGFLAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGF-like, fibronectin type-III and laminin G-like domain-containing protein (EGFLAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call